These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35006491)

  • 1. Synthesis and Evaluation of Radioiodine-Labeled pH (Low) Insertion Peptide Variant 7-Like Peptide as a Noninvasive Tumor Microenvironment Imaging Agent in a Mouse MDA-MB-231 Triple-Negative Breast Cancer Model.
    Wu F; Chen Y; Li D; Wang Z; Yu M
    Mol Imaging Biol; 2022 Aug; 24(4):570-579. PubMed ID: 35006491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Technetium-99m-Labeled pH (Low) Insertion Peptide Variant 7 for Early Diagnosis of MDA-MB-231 Triple-Negative Breast Cancer by Targeting the Tumor Microenvironment.
    Chen Y; Su Y; Pang X; Song X; Zhao W; Yu M
    Front Oncol; 2022; 12():869260. PubMed ID: 35530359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Experimental Study on [
    Yu M; Sun Y; Yang G; Wang Z
    Mol Imaging; 2021; 2021():5565932. PubMed ID: 33746628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of MDA-MB-231 cell proliferation by pHLIP(Var7)-P1AP and SPECT imaging of MDA-MB-231 breast cancer-bearing nude mice using 125I-pHLIP(Var7)-P1AP.
    Chen YH; Yu MM; Wang ZG
    Nuklearmedizin; 2021 Jun; 60(3):240-248. PubMed ID: 33759146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
    Yu M; Chen Y; Wang Z; Ding X
    Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.
    Zhang M; Xi Y; Chen H; Hai W; Li B
    Mol Imaging; 2022; 2022():7456365. PubMed ID: 35903249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small animal PET imaging with the
    Chen Y; Song S; Sun Y; Wu F; Yang G; Wang Z; Yu M
    EJNMMI Radiopharm Chem; 2024 Apr; 9(1):33. PubMed ID: 38678139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
    Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
    Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive Classification of Human Triple Negative Breast Cancer by PET Imaging with GRP78-Targeted Molecular Probe [
    Zhao H; Meng H; Wen J; Wang C; Liu J; Huang G
    Mol Imaging Biol; 2020 Jun; 22(3):772-779. PubMed ID: 31452065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panitumumab-DOTA-
    Facca VJ; Cai Z; Gopal NEK; Reilly RM
    Mol Pharm; 2022 Oct; 19(10):3652-3663. PubMed ID: 35926098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET Imaging of Extracellular pH in Tumors with (64)Cu- and (18)F-Labeled pHLIP Peptides: A Structure-Activity Optimization Study.
    Demoin DW; Wyatt LC; Edwards KJ; Abdel-Atti D; Sarparanta M; Pourat J; Longo VA; Carlin SD; Engelman DM; Andreev OA; Reshetnyak YK; Viola-Villegas N; Lewis JS
    Bioconjug Chem; 2016 Sep; 27(9):2014-23. PubMed ID: 27396694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radionuclide Molecular Imaging of EpCAM Expression in Triple-Negative Breast Cancer Using the Scaffold Protein DARPin Ec1.
    Vorobyeva A; Bezverkhniaia E; Konovalova E; Schulga A; Garousi J; Vorontsova O; Abouzayed A; Orlova A; Deyev S; Tolmachev V
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33066684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
    Burns KE; Robinson MK; Thévenin D
    Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
    Svoronos AA; Engelman DM
    Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 111In-labeled galectin-3-targeting peptide as a SPECT agent for imaging breast tumors.
    Kumar SR; Deutscher SL
    J Nucl Med; 2008 May; 49(5):796-803. PubMed ID: 18413389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of [
    Cavaliere A; Sun S; Lee S; Bodner J; Li Z; Huang Y; Moores SL; Marquez-Nostra B
    Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):383-394. PubMed ID: 32770372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart Design of a pH-Responsive System Based on pHLIP-Modified Magnetite Nanoparticles for Tumor MRI.
    Demin AM; Pershina AG; Minin AS; Brikunova OY; Murzakaev AM; Perekucha NA; Romashchenko AV; Shevelev OB; Uimin MA; Byzov IV; Malkeyeva D; Kiseleva E; Efimova LV; Vtorushin SV; Ogorodova LM; Krasnov VP
    ACS Appl Mater Interfaces; 2021 Aug; 13(31):36800-36815. PubMed ID: 34324807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo pH imaging with (99m)Tc-pHLIP.
    Macholl S; Morrison MS; Iveson P; Arbo BE; Andreev OA; Reshetnyak YK; Engelman DM; Johannesen E
    Mol Imaging Biol; 2012 Dec; 14(6):725-34. PubMed ID: 22371188
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.